Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
The Indian stock market faces selling pressure due to high valuations and global economic uncertainties, impacting the IPO market. Despite increased listing activities, investor interest wanes, ...